[HTML][HTML] Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam

VAT Cao, TQ Nguyen, D Le Quyen, WPC Boon… - Malaria journal, 2023 - Springer
Background This study investigates the processes regarding changing malaria treatment
policies in Vietnam. Moreover, it explores the feasibility of introducing triple artemisinin …

[HTML][HTML] Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion

F de Haan, C Amaratunga, VAC Thi, LH Orng… - Malaria journal, 2023 - Springer
Background This is a qualitative study to identify implementation challenges for deploying
triple artemisinin-based combination therapy (TACT) in the Greater Mekong Subregion …

[HTML][HTML] Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study

F de Haan, WPC Boon, C Amaratunga, AM Dondorp - BMC Public Health, 2022 - Springer
Abstract Background Triple Artemisinin-based Combination Therapies (TACTs) are being
developed as a response to artemisinin and partner drug resistance in Southeast Asia …

Ethical, regulatory and market related aspects of deploying triple artemisinin-based combination therapies for malaria treatment in Africa

OA Bolarinwa, OA Mokuolu… - The Global Health …, 2023 - tghncollections.pubpub.org
Methods: We employed qualitative research methods involving in-depth interviews and
focus group discussions (FGDs) with relevant stakeholders. We used a multiple case design …

[HTML][HTML] Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations

P Tindana, F de Haan, C Amaratunga, M Dhorda… - Malaria Journal, 2021 - Springer
Malaria remains a major cause of morbidity and mortality in Africa, particularly in children
under five years of age. Availability of effective anti-malarial drug treatment is a cornerstone …

[HTML][HTML] To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?

F De Haan, OA Bolarinwa, R Guissou, F Tou… - PLoS …, 2021 - journals.plos.org
Introduction Triple artemisinin-based combination therapies (TACTs) are being developed
as a response to artemisinin and partner drug resistance in the treatment of falciparum …

[HTML][HTML] Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.

P Tindana, F de Haan, OA Mokuolu… - Wellcome open …, 2021 - ncbi.nlm.nih.gov
Abstract Introduction: According to the World Malaria Report 2019, Africa accounts for 94%
of the global malaria deaths. While malaria prevalence and mortality have declined over the …

[HTML][HTML] Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts

E Kokori, G Olatunji, A Akinboade, A Akinoso… - Malaria Journal, 2024 - Springer
This paper examines the far-reaching implications of Triple Artemisinin-Based Combination
Therapy (TACT) in the global battle against malaria. Artemisinin-Based Combination …

[HTML][HTML] Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: an analysis of stakeholders' perspectives in Burkina Faso and …

P Tindana, R Guissou, OA Bolarinwa, F Tou… - PLoS …, 2022 - journals.plos.org
Background Artemisinin-based combination therapies (ACTs) are the recommended
treatment for uncomplicated Plasmodium falciparum malaria in all malaria endemic …

[HTML][HTML] The decline of malaria in Vietnam, 1991–2014

SM Goldlust, PD Thuan, DDH Giang, ND Thang… - Malaria journal, 2018 - Springer
Background Despite the well-documented clinical efficacy of artemisinin-based combination
therapy (ACT) against malaria, the population-level effects of ACT have not been studied …